Claudia Kimie Suemoto1, Daniel Apolinario2, Ester Miyuki Nakamura-Palacios3, Leonardo Lopes2, Renata Elaine Paraizo Leite4, Manuela Castro Sales2, Ricardo Nitrini5, Sonia Maria Brucki5, Lilian Shafirovitz Morillo2, Regina Miksian Magaldi2, Felipe Fregni6. 1. Discipline of Geriatrics, Department of Internal Medicine, University of Sao Paulo Medical School, Sao Paulo, Sao Paulo, Brazil. Electronic address: cksuemoto@usp.br. 2. Discipline of Geriatrics, Department of Internal Medicine, University of Sao Paulo Medical School, Sao Paulo, Sao Paulo, Brazil. 3. Department of Physiological Sciences, Federal University of Espirito Santo, Vitoria, Espirito Santo, Brazil. 4. Department of Pathology, LIM/22, University of Sao Paulo Medical School, Sao Paulo, Sao Paulo, Brazil. 5. Department of Neurology, University of Sao Paulo Medical School, Sao Paulo, Sao Paulo, Brazil. 6. Department of Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital and Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Abstract
BACKGROUND: Apathy is the most common neuropsychiatric symptom in Alzheimer's disease (AD) and it is associated with changes in prefrontal neural circuits involved with generation of voluntary actions. To date no effective treatment for apathy has been demonstrated. OBJECTIVE: We aimed to investigate the effects and safety of repetitive transcranial direct current stimulation (tDCS) on apathy in moderate AD patients. METHODS:Forty patients were randomized to receive either active or sham-tDCS over the left dorsolateral prefrontal cortex (DLPFC). Patients received six sessions of intervention during 2 weeks and were evaluated at baseline, at week 1 and 2, and after 1 week without intervention. Clinical raters, patients, and caregivers were blinded. The primary outcome was apathy. Global cognition and neuropsychiatric symptoms were examined as secondary outcomes. RESULTS: The mean MMSE score at baseline was 15.2 ± 2.9 and the mean Apathy Scale score was 27.7 ± 6.7. Changes on apathy scores over time were not different between active and sham tDCS (P = 0.552 for repeated measures). Further analyses confirm that changes from baseline did not differ between groups after the sixth session (active tDCS -1.95 (95%CI -3.49, -0.41); sham-tDCS -2.05 (95%CI -3.68, -0.42); P = 0.989]. Similarly, tDCS had no effect on secondary outcomes (P > 0.40). tDCS was well tolerated and not associated with significant adverse effects. CONCLUSION: In this adequately powered study for minimal clinically significant difference, our findings show that using the parameters we chose for this study, repeated anodal tDCS over the left DLPFC had no effect on apathy in elderly patients with moderate AD.
RCT Entities:
BACKGROUND: Apathy is the most common neuropsychiatric symptom in Alzheimer's disease (AD) and it is associated with changes in prefrontal neural circuits involved with generation of voluntary actions. To date no effective treatment for apathy has been demonstrated. OBJECTIVE: We aimed to investigate the effects and safety of repetitive transcranial direct current stimulation (tDCS) on apathy in moderate ADpatients. METHODS: Forty patients were randomized to receive either active or sham-tDCS over the left dorsolateral prefrontal cortex (DLPFC). Patients received six sessions of intervention during 2 weeks and were evaluated at baseline, at week 1 and 2, and after 1 week without intervention. Clinical raters, patients, and caregivers were blinded. The primary outcome was apathy. Global cognition and neuropsychiatric symptoms were examined as secondary outcomes. RESULTS: The mean MMSE score at baseline was 15.2 ± 2.9 and the mean Apathy Scale score was 27.7 ± 6.7. Changes on apathy scores over time were not different between active and sham tDCS (P = 0.552 for repeated measures). Further analyses confirm that changes from baseline did not differ between groups after the sixth session (active tDCS -1.95 (95%CI -3.49, -0.41); sham-tDCS -2.05 (95%CI -3.68, -0.42); P = 0.989]. Similarly, tDCS had no effect on secondary outcomes (P > 0.40). tDCS was well tolerated and not associated with significant adverse effects. CONCLUSION: In this adequately powered study for minimal clinically significant difference, our findings show that using the parameters we chose for this study, repeated anodal tDCS over the left DLPFC had no effect on apathy in elderly patients with moderate AD.
Authors: Noah S Philip; Brent G Nelson; Flavio Frohlich; Kelvin O Lim; Alik S Widge; Linda L Carpenter Journal: Am J Psychiatry Date: 2017-02-24 Impact factor: 18.112
Authors: Bruce Crosson; Benjamin M Hampstead; Lisa C Krishnamurthy; Venkatagiri Krishnamurthy; Keith M McGregor; Joe R Nocera; Simone Roberts; Amy D Rodriguez; Stella M Tran Journal: Neuropsychology Date: 2017-08-31 Impact factor: 3.295
Authors: Prasad R Padala; Kalpana P Padala; Shelly Y Lensing; Andrea N Jackson; Cassandra R Hunter; Christopher M Parkes; Richard A Dennis; Melinda M Bopp; Ricardo Caceda; Mark S Mennemeier; Paula K Roberson; Dennis H Sullivan Journal: Psychiatry Res Date: 2018-01-05 Impact factor: 3.222
Authors: Marom Bikson; Pnina Grossman; Chris Thomas; Adantchede Louis Zannou; Jimmy Jiang; Tatheer Adnan; Antonios P Mourdoukoutas; Greg Kronberg; Dennis Truong; Paulo Boggio; André R Brunoni; Leigh Charvet; Felipe Fregni; Brita Fritsch; Bernadette Gillick; Roy H Hamilton; Benjamin M Hampstead; Ryan Jankord; Adam Kirton; Helena Knotkova; David Liebetanz; Anli Liu; Colleen Loo; Michael A Nitsche; Janine Reis; Jessica D Richardson; Alexander Rotenberg; Peter E Turkeltaub; Adam J Woods Journal: Brain Stimul Date: 2016-06-15 Impact factor: 8.955
Authors: Emma Gulley; Joe Verghese; Helena M Blumen; Emmeline Ayers; Cuiling Wang; Russell K Portenoy; Jessica L Zwerling; Erica Weiss; Helena Knotkova Journal: Neurodegener Dis Manag Date: 2021-07-09